nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—Corticosteroid Hormone Receptor Agonists—Prednisone—Crohn's disease	0.308	1	CiPCiCtD
Hydrocortisone—ulcerative colitis—Crohn's disease	0.215	1	CtDrD
Hydrocortisone—Prednisone—Crohn's disease	0.21	1	CrCtD
Hydrocortisone—NR3C1—Prednisone—Crohn's disease	0.0189	0.287	CbGbCtD
Hydrocortisone—SLCO1A2—Prednisone—Crohn's disease	0.0162	0.247	CbGbCtD
Hydrocortisone—ABCG2—Sulfasalazine—Crohn's disease	0.0152	0.232	CbGbCtD
Hydrocortisone—Potassium Canrenoate—Prednisone—Crohn's disease	0.00982	0.0649	CrCrCtD
Hydrocortisone—Ciclesonide—Prednisone—Crohn's disease	0.00862	0.057	CrCrCtD
Hydrocortisone—CYP3A5—Sulfasalazine—Crohn's disease	0.00844	0.128	CbGbCtD
Hydrocortisone—Danazol—Prednisone—Crohn's disease	0.00829	0.0548	CrCrCtD
Hydrocortisone—Hydrocortamate—Prednisone—Crohn's disease	0.00721	0.0477	CrCrCtD
Hydrocortisone—Cortisone acetate—Prednisone—Crohn's disease	0.00699	0.0462	CrCrCtD
Hydrocortisone—Prednicarbate—Prednisone—Crohn's disease	0.00678	0.0448	CrCrCtD
Hydrocortisone—Alclometasone—Prednisone—Crohn's disease	0.00641	0.0423	CrCrCtD
Hydrocortisone—Budesonide—Prednisone—Crohn's disease	0.00623	0.0412	CrCrCtD
Hydrocortisone—Desonide—Prednisone—Crohn's disease	0.00607	0.0401	CrCrCtD
Hydrocortisone—Flunisolide—Prednisone—Crohn's disease	0.00607	0.0401	CrCrCtD
Hydrocortisone—Fludrocortisone—Prednisone—Crohn's disease	0.00607	0.0401	CrCrCtD
Hydrocortisone—Methyltestosterone—Prednisone—Crohn's disease	0.00592	0.0391	CrCrCtD
Hydrocortisone—Paramethasone—Prednisone—Crohn's disease	0.00592	0.0391	CrCrCtD
Hydrocortisone—Desoximetasone—Prednisone—Crohn's disease	0.00578	0.0382	CrCrCtD
Hydrocortisone—Loteprednol—Prednisone—Crohn's disease	0.00564	0.0373	CrCrCtD
Hydrocortisone—Triamcinolone—Prednisone—Crohn's disease	0.00564	0.0373	CrCrCtD
Hydrocortisone—Fluorometholone—Prednisone—Crohn's disease	0.00564	0.0373	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Prednisone—Crohn's disease	0.00564	0.0373	CrCrCtD
Hydrocortisone—Mometasone—Prednisone—Crohn's disease	0.00564	0.0373	CrCrCtD
Hydrocortisone—Dexamethasone—Prednisone—Crohn's disease	0.00551	0.0364	CrCrCtD
Hydrocortisone—Rimexolone—Prednisone—Crohn's disease	0.00551	0.0364	CrCrCtD
Hydrocortisone—Betamethasone—Prednisone—Crohn's disease	0.00551	0.0364	CrCrCtD
Hydrocortisone—Methylprednisolone—Prednisone—Crohn's disease	0.00527	0.0348	CrCrCtD
Hydrocortisone—Prednisolone—Prednisone—Crohn's disease	0.00516	0.0341	CrCrCtD
Hydrocortisone—ABCB1—Prednisone—Crohn's disease	0.00439	0.0667	CbGbCtD
Hydrocortisone—CYP3A4—Prednisone—Crohn's disease	0.00263	0.04	CbGbCtD
Hydrocortisone—ANXA1—gall bladder—Crohn's disease	0.000426	0.137	CbGeAlD
Hydrocortisone—ANXA1—mouth—Crohn's disease	0.000379	0.122	CbGeAlD
Hydrocortisone—ANXA1—epithelium—Crohn's disease	0.00022	0.0708	CbGeAlD
Hydrocortisone—ANXA1—smooth muscle tissue—Crohn's disease	0.000212	0.0682	CbGeAlD
Hydrocortisone—ANXA1—skin of body—Crohn's disease	0.00021	0.0673	CbGeAlD
Hydrocortisone—ANXA1—mammalian vulva—Crohn's disease	0.000191	0.0614	CbGeAlD
Hydrocortisone—ANXA1—lymphoid tissue—Crohn's disease	0.00017	0.0545	CbGeAlD
Hydrocortisone—ANXA1—digestive system—Crohn's disease	0.000168	0.0538	CbGeAlD
Hydrocortisone—Leukoderma—Prednisone—Crohn's disease	0.00016	0.00385	CcSEcCtD
Hydrocortisone—Cognitive disorder—Prednisone—Crohn's disease	0.000157	0.00379	CcSEcCtD
Hydrocortisone—Impaired healing—Prednisone—Crohn's disease	0.000157	0.00379	CcSEcCtD
Hydrocortisone—Intraocular pressure increased—Prednisone—Crohn's disease	0.000154	0.00372	CcSEcCtD
Hydrocortisone—Acne—Mesalazine—Crohn's disease	0.000153	0.00368	CcSEcCtD
Hydrocortisone—Pancreatitis acute—Prednisone—Crohn's disease	0.000147	0.00355	CcSEcCtD
Hydrocortisone—Amenorrhoea—Mesalazine—Crohn's disease	0.000146	0.00352	CcSEcCtD
Hydrocortisone—Pancreatitis—Mercaptopurine—Crohn's disease	0.000145	0.00351	CcSEcCtD
Hydrocortisone—Vasculitis—Azathioprine—Crohn's disease	0.000144	0.00348	CcSEcCtD
Hydrocortisone—Trauma—Prednisone—Crohn's disease	0.000143	0.00344	CcSEcCtD
Hydrocortisone—Skin discolouration—Mesalazine—Crohn's disease	0.000142	0.00343	CcSEcCtD
Hydrocortisone—Rectal haemorrhage—Mesalazine—Crohn's disease	0.000142	0.00343	CcSEcCtD
Hydrocortisone—Arthropathy—Mesalazine—Crohn's disease	0.000141	0.0034	CcSEcCtD
Hydrocortisone—CYP11B2—lymph node—Crohn's disease	0.000141	0.0451	CbGeAlD
Hydrocortisone—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.000138	0.00334	CcSEcCtD
Hydrocortisone—Leukocytosis—Mesalazine—Crohn's disease	0.000137	0.00329	CcSEcCtD
Hydrocortisone—Embolism venous—Prednisone—Crohn's disease	0.000135	0.00324	CcSEcCtD
Hydrocortisone—Hypernatraemia—Prednisone—Crohn's disease	0.000129	0.00311	CcSEcCtD
Hydrocortisone—Menstruation irregular—Prednisone—Crohn's disease	0.000123	0.00296	CcSEcCtD
Hydrocortisone—Skin exfoliation—Mesalazine—Crohn's disease	0.000123	0.00295	CcSEcCtD
Hydrocortisone—Osteoporosis—Prednisone—Crohn's disease	0.000121	0.00292	CcSEcCtD
Hydrocortisone—Neuropathy—Mesalazine—Crohn's disease	0.00012	0.00291	CcSEcCtD
Hydrocortisone—Dry eye—Mesalazine—Crohn's disease	0.000119	0.00286	CcSEcCtD
Hydrocortisone—Hirsutism—Prednisone—Crohn's disease	0.000117	0.00282	CcSEcCtD
Hydrocortisone—Fracture—Prednisone—Crohn's disease	0.000117	0.00282	CcSEcCtD
Hydrocortisone—Multiple fractures—Prednisone—Crohn's disease	0.000117	0.00282	CcSEcCtD
Hydrocortisone—Ecchymosis—Mesalazine—Crohn's disease	0.000116	0.0028	CcSEcCtD
Hydrocortisone—Optic neuritis—Prednisone—Crohn's disease	0.00011	0.00266	CcSEcCtD
Hydrocortisone—Immune system disorder—Mercaptopurine—Crohn's disease	0.000107	0.00259	CcSEcCtD
Hydrocortisone—Embolism—Prednisone—Crohn's disease	0.000106	0.00255	CcSEcCtD
Hydrocortisone—Gastroenteritis—Mesalazine—Crohn's disease	0.000105	0.00253	CcSEcCtD
Hydrocortisone—Eczema—Mesalazine—Crohn's disease	0.000104	0.0025	CcSEcCtD
Hydrocortisone—Malnutrition—Mercaptopurine—Crohn's disease	0.000103	0.00249	CcSEcCtD
Hydrocortisone—Peptic ulcer—Prednisone—Crohn's disease	0.000102	0.00245	CcSEcCtD
Hydrocortisone—Increased appetite—Mesalazine—Crohn's disease	9.92e-05	0.00239	CcSEcCtD
Hydrocortisone—Myopathy—Prednisone—Crohn's disease	9.68e-05	0.00233	CcSEcCtD
Hydrocortisone—Suicidal ideation—Prednisone—Crohn's disease	9.68e-05	0.00233	CcSEcCtD
Hydrocortisone—Hepatomegaly—Prednisone—Crohn's disease	9.59e-05	0.00231	CcSEcCtD
Hydrocortisone—Delusion—Prednisone—Crohn's disease	9.59e-05	0.00231	CcSEcCtD
Hydrocortisone—ANXA1—lymph node—Crohn's disease	9.58e-05	0.0308	CbGeAlD
Hydrocortisone—Lethargy—Mesalazine—Crohn's disease	9.51e-05	0.00229	CcSEcCtD
Hydrocortisone—Mania—Prednisone—Crohn's disease	9.34e-05	0.00225	CcSEcCtD
Hydrocortisone—Osteoarthritis—Mesalazine—Crohn's disease	9.32e-05	0.00225	CcSEcCtD
Hydrocortisone—SLCO1A2—digestive system—Crohn's disease	9.31e-05	0.0299	CbGeAlD
Hydrocortisone—Affect lability—Mesalazine—Crohn's disease	9.17e-05	0.00221	CcSEcCtD
Hydrocortisone—Neuritis—Prednisone—Crohn's disease	9.09e-05	0.00219	CcSEcCtD
Hydrocortisone—Glaucoma—Prednisone—Crohn's disease	9.02e-05	0.00217	CcSEcCtD
Hydrocortisone—Mood swings—Mesalazine—Crohn's disease	8.82e-05	0.00213	CcSEcCtD
Hydrocortisone—Fungal infection—Prednisone—Crohn's disease	8.79e-05	0.00212	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	8.74e-05	0.00211	CcSEcCtD
Hydrocortisone—Pancreatitis—Azathioprine—Crohn's disease	8.67e-05	0.00209	CcSEcCtD
Hydrocortisone—Necrosis—Prednisone—Crohn's disease	8.65e-05	0.00209	CcSEcCtD
Hydrocortisone—Abscess—Prednisone—Crohn's disease	8.58e-05	0.00207	CcSEcCtD
Hydrocortisone—Dry skin—Mesalazine—Crohn's disease	8.54e-05	0.00206	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Mesalazine—Crohn's disease	8.51e-05	0.00205	CcSEcCtD
Hydrocortisone—Oedema—Mercaptopurine—Crohn's disease	8.44e-05	0.00203	CcSEcCtD
Hydrocortisone—Glycosuria—Prednisone—Crohn's disease	8.38e-05	0.00202	CcSEcCtD
Hydrocortisone—Petechiae—Prednisone—Crohn's disease	8.25e-05	0.00199	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Mesalazine—Crohn's disease	8.22e-05	0.00198	CcSEcCtD
Hydrocortisone—Skin disorder—Mercaptopurine—Crohn's disease	8.19e-05	0.00198	CcSEcCtD
Hydrocortisone—Endocrine disorder—Prednisone—Crohn's disease	8.19e-05	0.00198	CcSEcCtD
Hydrocortisone—Abdominal distension—Mesalazine—Crohn's disease	8.11e-05	0.00195	CcSEcCtD
Hydrocortisone—Acne—Prednisone—Crohn's disease	8.07e-05	0.00195	CcSEcCtD
Hydrocortisone—Anorexia—Mercaptopurine—Crohn's disease	8.04e-05	0.00194	CcSEcCtD
Hydrocortisone—Pancreatitis—Mesalazine—Crohn's disease	7.89e-05	0.0019	CcSEcCtD
Hydrocortisone—Infestation NOS—Azathioprine—Crohn's disease	7.88e-05	0.0019	CcSEcCtD
Hydrocortisone—Infestation—Azathioprine—Crohn's disease	7.88e-05	0.0019	CcSEcCtD
Hydrocortisone—Contusion—Prednisone—Crohn's disease	7.78e-05	0.00188	CcSEcCtD
Hydrocortisone—Amenorrhoea—Prednisone—Crohn's disease	7.73e-05	0.00186	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	7.69e-05	0.00185	CcSEcCtD
Hydrocortisone—NR3C1—epithelium—Crohn's disease	7.66e-05	0.0246	CbGeAlD
Hydrocortisone—ANXA1—G alpha (q) signalling events—GPR65—Crohn's disease	7.6e-05	0.0147	CbGpPWpGaD
Hydrocortisone—Viral infection—Prednisone—Crohn's disease	7.52e-05	0.00181	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Mesalazine—Crohn's disease	7.48e-05	0.0018	CcSEcCtD
Hydrocortisone—Arthropathy—Prednisone—Crohn's disease	7.47e-05	0.0018	CcSEcCtD
Hydrocortisone—NR3C1—smooth muscle tissue—Crohn's disease	7.38e-05	0.0237	CbGeAlD
Hydrocortisone—Decreased appetite—Mercaptopurine—Crohn's disease	7.33e-05	0.00177	CcSEcCtD
Hydrocortisone—Weight increased—Mesalazine—Crohn's disease	7.33e-05	0.00177	CcSEcCtD
Hydrocortisone—Weight decreased—Mesalazine—Crohn's disease	7.28e-05	0.00176	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	7.28e-05	0.00176	CcSEcCtD
Hydrocortisone—NR3C1—skin of body—Crohn's disease	7.28e-05	0.0234	CbGeAlD
Hydrocortisone—Leukocytosis—Prednisone—Crohn's disease	7.22e-05	0.00174	CcSEcCtD
Hydrocortisone—ABCG2—mammalian vulva—Crohn's disease	7.21e-05	0.0232	CbGeAlD
Hydrocortisone—Infestation NOS—Mesalazine—Crohn's disease	7.18e-05	0.00173	CcSEcCtD
Hydrocortisone—Infestation—Mesalazine—Crohn's disease	7.18e-05	0.00173	CcSEcCtD
Hydrocortisone—Cataract—Prednisone—Crohn's disease	7.13e-05	0.00172	CcSEcCtD
Hydrocortisone—Haemoglobin—Azathioprine—Crohn's disease	7.11e-05	0.00171	CcSEcCtD
Hydrocortisone—Haemorrhage—Azathioprine—Crohn's disease	7.08e-05	0.00171	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Mesalazine—Crohn's disease	7.04e-05	0.0017	CcSEcCtD
Hydrocortisone—Vasculitis—Prednisone—Crohn's disease	6.96e-05	0.00168	CcSEcCtD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CCR9—Crohn's disease	6.81e-05	0.0132	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	6.8e-05	0.0131	CbGpPWpGaD
Hydrocortisone—Hiccups—Prednisone—Crohn's disease	6.79e-05	0.00164	CcSEcCtD
Hydrocortisone—Body temperature increased—Mercaptopurine—Crohn's disease	6.67e-05	0.00161	CcSEcCtD
Hydrocortisone—NR3C1—mammalian vulva—Crohn's disease	6.64e-05	0.0213	CbGeAlD
Hydrocortisone—Skin exfoliation—Prednisone—Crohn's disease	6.48e-05	0.00156	CcSEcCtD
Hydrocortisone—Haemoglobin—Mesalazine—Crohn's disease	6.48e-05	0.00156	CcSEcCtD
Hydrocortisone—Fluid retention—Prednisone—Crohn's disease	6.45e-05	0.00155	CcSEcCtD
Hydrocortisone—Haemorrhage—Mesalazine—Crohn's disease	6.44e-05	0.00155	CcSEcCtD
Hydrocortisone—Immune system disorder—Azathioprine—Crohn's disease	6.39e-05	0.00154	CcSEcCtD
Hydrocortisone—Neuropathy—Prednisone—Crohn's disease	6.37e-05	0.00154	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Mesalazine—Crohn's disease	6.33e-05	0.00153	CcSEcCtD
Hydrocortisone—Arrhythmia—Azathioprine—Crohn's disease	6.32e-05	0.00152	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—ACKR2—Crohn's disease	6.27e-05	0.0121	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Mercaptopurine—Crohn's disease	6.22e-05	0.0015	CcSEcCtD
Hydrocortisone—Oesophagitis—Prednisone—Crohn's disease	6.2e-05	0.0015	CcSEcCtD
Hydrocortisone—Ecchymosis—Prednisone—Crohn's disease	6.14e-05	0.00148	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Prednisone—Crohn's disease	6.04e-05	0.00146	CcSEcCtD
Hydrocortisone—Eye disorder—Mesalazine—Crohn's disease	6.02e-05	0.00145	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—MLN—Crohn's disease	5.95e-05	0.0115	CbGpPWpGaD
Hydrocortisone—Testosterone—SLC22A4—Crohn's disease	5.9e-05	0.246	CrCbGaD
Hydrocortisone—NR3C1—lymphoid tissue—Crohn's disease	5.9e-05	0.0189	CbGeAlD
Hydrocortisone—CYP3A5—digestive system—Crohn's disease	5.87e-05	0.0188	CbGeAlD
Hydrocortisone—Euphoric mood—Prednisone—Crohn's disease	5.83e-05	0.00141	CcSEcCtD
Hydrocortisone—SLCO1A2—Recycling of bile acids and salts—ALB—Crohn's disease	5.83e-05	0.0113	CbGpPWpGaD
Hydrocortisone—NR3C1—digestive system—Crohn's disease	5.82e-05	0.0187	CbGeAlD
Hydrocortisone—Immune system disorder—Mesalazine—Crohn's disease	5.82e-05	0.0014	CcSEcCtD
Hydrocortisone—Diarrhoea—Mercaptopurine—Crohn's disease	5.77e-05	0.00139	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Azathioprine—Crohn's disease	5.71e-05	0.00138	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Prednisone—Crohn's disease	5.69e-05	0.00137	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Prednisone—Crohn's disease	5.67e-05	0.00137	CcSEcCtD
Hydrocortisone—Mental disorder—Mesalazine—Crohn's disease	5.65e-05	0.00136	CcSEcCtD
Hydrocortisone—Erythema—Mesalazine—Crohn's disease	5.61e-05	0.00135	CcSEcCtD
Hydrocortisone—Malaise—Azathioprine—Crohn's disease	5.55e-05	0.00134	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Prednisone—Crohn's disease	5.43e-05	0.00131	CcSEcCtD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	5.41e-05	0.0105	CbGpPWpGaD
Hydrocortisone—Vomiting—Mercaptopurine—Crohn's disease	5.36e-05	0.00129	CcSEcCtD
Hydrocortisone—Injury—Prednisone—Crohn's disease	5.36e-05	0.00129	CcSEcCtD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CCR6—Crohn's disease	5.35e-05	0.0103	CbGpPWpGaD
Hydrocortisone—Rash—Mercaptopurine—Crohn's disease	5.32e-05	0.00128	CcSEcCtD
Hydrocortisone—Dermatitis—Mercaptopurine—Crohn's disease	5.31e-05	0.00128	CcSEcCtD
Hydrocortisone—Increased appetite—Prednisone—Crohn's disease	5.25e-05	0.00127	CcSEcCtD
Hydrocortisone—Myalgia—Azathioprine—Crohn's disease	5.24e-05	0.00126	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	5.21e-05	0.00126	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Mesalazine—Crohn's disease	5.21e-05	0.00126	CcSEcCtD
Hydrocortisone—Discomfort—Azathioprine—Crohn's disease	5.18e-05	0.00125	CcSEcCtD
Hydrocortisone—CYP11B2—Metapathway biotransformation—GPX4—Crohn's disease	5.18e-05	0.01	CbGpPWpGaD
Hydrocortisone—Angioedema—Mesalazine—Crohn's disease	5.13e-05	0.00124	CcSEcCtD
Hydrocortisone—Malaise—Mesalazine—Crohn's disease	5.06e-05	0.00122	CcSEcCtD
Hydrocortisone—Cardiac failure—Prednisone—Crohn's disease	5.05e-05	0.00122	CcSEcCtD
Hydrocortisone—Vertigo—Mesalazine—Crohn's disease	5.04e-05	0.00122	CcSEcCtD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	5.03e-05	0.00973	CbGpPWpGaD
Hydrocortisone—Syncope—Mesalazine—Crohn's disease	5.03e-05	0.00121	CcSEcCtD
Hydrocortisone—Lethargy—Prednisone—Crohn's disease	5.03e-05	0.00121	CcSEcCtD
Hydrocortisone—Nausea—Mercaptopurine—Crohn's disease	5.01e-05	0.00121	CcSEcCtD
Hydrocortisone—Infection—Azathioprine—Crohn's disease	4.99e-05	0.0012	CcSEcCtD
Hydrocortisone—Loss of consciousness—Mesalazine—Crohn's disease	4.93e-05	0.00119	CcSEcCtD
Hydrocortisone—Osteoarthritis—Prednisone—Crohn's disease	4.93e-05	0.00119	CcSEcCtD
Hydrocortisone—Skin disorder—Azathioprine—Crohn's disease	4.88e-05	0.00118	CcSEcCtD
Hydrocortisone—Affect lability—Prednisone—Crohn's disease	4.85e-05	0.00117	CcSEcCtD
Hydrocortisone—Hypertension—Mesalazine—Crohn's disease	4.84e-05	0.00117	CcSEcCtD
Hydrocortisone—Psychotic disorder—Prednisone—Crohn's disease	4.81e-05	0.00116	CcSEcCtD
Hydrocortisone—Myalgia—Mesalazine—Crohn's disease	4.78e-05	0.00115	CcSEcCtD
Hydrocortisone—Anxiety—Mesalazine—Crohn's disease	4.76e-05	0.00115	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	4.74e-05	0.00114	CcSEcCtD
Hydrocortisone—Discomfort—Mesalazine—Crohn's disease	4.72e-05	0.00114	CcSEcCtD
Hydrocortisone—Irritability—Prednisone—Crohn's disease	4.7e-05	0.00113	CcSEcCtD
Hydrocortisone—Hypotension—Azathioprine—Crohn's disease	4.7e-05	0.00113	CcSEcCtD
Hydrocortisone—Cardiac arrest—Prednisone—Crohn's disease	4.69e-05	0.00113	CcSEcCtD
Hydrocortisone—Mood swings—Prednisone—Crohn's disease	4.67e-05	0.00113	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	4.58e-05	0.0011	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Mesalazine—Crohn's disease	4.58e-05	0.0011	CcSEcCtD
Hydrocortisone—Oedema—Mesalazine—Crohn's disease	4.58e-05	0.0011	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	4.56e-05	0.00882	CbGpPWpGaD
Hydrocortisone—Infection—Mesalazine—Crohn's disease	4.55e-05	0.0011	CcSEcCtD
Hydrocortisone—Dry skin—Prednisone—Crohn's disease	4.52e-05	0.00109	CcSEcCtD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CCR6—Crohn's disease	4.51e-05	0.00872	CbGpPWpGaD
Hydrocortisone—Shock—Mesalazine—Crohn's disease	4.5e-05	0.00109	CcSEcCtD
Hydrocortisone—Nervous system disorder—Mesalazine—Crohn's disease	4.49e-05	0.00108	CcSEcCtD
Hydrocortisone—Hypokalaemia—Prednisone—Crohn's disease	4.49e-05	0.00108	CcSEcCtD
Hydrocortisone—Tachycardia—Mesalazine—Crohn's disease	4.47e-05	0.00108	CcSEcCtD
Hydrocortisone—CYP11B1—Metapathway biotransformation—GPX4—Crohn's disease	4.46e-05	0.00863	CbGpPWpGaD
Hydrocortisone—Skin disorder—Mesalazine—Crohn's disease	4.45e-05	0.00107	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Mesalazine—Crohn's disease	4.43e-05	0.00107	CcSEcCtD
Hydrocortisone—CYP3A4—digestive system—Crohn's disease	4.4e-05	0.0141	CbGeAlD
Hydrocortisone—Anorexia—Mesalazine—Crohn's disease	4.36e-05	0.00105	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Prednisone—Crohn's disease	4.35e-05	0.00105	CcSEcCtD
Hydrocortisone—Muscular weakness—Prednisone—Crohn's disease	4.35e-05	0.00105	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Azathioprine—Crohn's disease	4.34e-05	0.00105	CcSEcCtD
Hydrocortisone—Abdominal distension—Prednisone—Crohn's disease	4.29e-05	0.00103	CcSEcCtD
Hydrocortisone—Hypotension—Mesalazine—Crohn's disease	4.28e-05	0.00103	CcSEcCtD
Hydrocortisone—Pancreatitis—Prednisone—Crohn's disease	4.18e-05	0.00101	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	4.17e-05	0.00101	CcSEcCtD
Hydrocortisone—Sweating increased—Prednisone—Crohn's disease	4.15e-05	0.001	CcSEcCtD
Hydrocortisone—Feeling abnormal—Azathioprine—Crohn's disease	4.14e-05	0.000999	CcSEcCtD
Hydrocortisone—Insomnia—Mesalazine—Crohn's disease	4.14e-05	0.000999	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—CCR9—Crohn's disease	4.12e-05	0.00797	CbGpPWpGaD
Hydrocortisone—Paraesthesia—Mesalazine—Crohn's disease	4.11e-05	0.000991	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Azathioprine—Crohn's disease	4.11e-05	0.000991	CcSEcCtD
Hydrocortisone—ABCB1—epithelium—Crohn's disease	4.1e-05	0.0132	CbGeAlD
Hydrocortisone—Dyspepsia—Mesalazine—Crohn's disease	4.03e-05	0.000972	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	3.99e-05	0.00772	CbGpPWpGaD
Hydrocortisone—Decreased appetite—Mesalazine—Crohn's disease	3.98e-05	0.00096	CcSEcCtD
Hydrocortisone—Abdominal pain—Azathioprine—Crohn's disease	3.97e-05	0.000958	CcSEcCtD
Hydrocortisone—Body temperature increased—Azathioprine—Crohn's disease	3.97e-05	0.000958	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Mesalazine—Crohn's disease	3.95e-05	0.000953	CcSEcCtD
Hydrocortisone—Fatigue—Mesalazine—Crohn's disease	3.95e-05	0.000952	CcSEcCtD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CREM—Crohn's disease	3.94e-05	0.00762	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (q) signalling events—RASGRP1—Crohn's disease	3.93e-05	0.0076	CbGpPWpGaD
Hydrocortisone—Pain—Mesalazine—Crohn's disease	3.92e-05	0.000944	CcSEcCtD
Hydrocortisone—Weight increased—Prednisone—Crohn's disease	3.88e-05	0.000935	CcSEcCtD
Hydrocortisone—Weight decreased—Prednisone—Crohn's disease	3.85e-05	0.000929	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—GPR65—Crohn's disease	3.83e-05	0.00741	CbGpPWpGaD
Hydrocortisone—Drospirenone—PTGS2—Crohn's disease	3.79e-05	0.158	CrCbGaD
Hydrocortisone—Feeling abnormal—Mesalazine—Crohn's disease	3.77e-05	0.00091	CcSEcCtD
Hydrocortisone—CYP2C8—Arachidonic acid metabolism—GPX4—Crohn's disease	3.75e-05	0.00724	CbGpPWpGaD
Hydrocortisone—Acute coronary syndrome—Prednisone—Crohn's disease	3.74e-05	0.000903	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Mesalazine—Crohn's disease	3.74e-05	0.000903	CcSEcCtD
Hydrocortisone—Myocardial infarction—Prednisone—Crohn's disease	3.72e-05	0.000898	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Prednisone—Crohn's disease	3.72e-05	0.000898	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—TLR4—Crohn's disease	3.72e-05	0.00719	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Azathioprine—Crohn's disease	3.7e-05	0.000893	CcSEcCtD
Hydrocortisone—Urticaria—Mesalazine—Crohn's disease	3.64e-05	0.000877	CcSEcCtD
Hydrocortisone—Abdominal pain—Mesalazine—Crohn's disease	3.62e-05	0.000873	CcSEcCtD
Hydrocortisone—Body temperature increased—Mesalazine—Crohn's disease	3.62e-05	0.000873	CcSEcCtD
Hydrocortisone—ABCG2—lymph node—Crohn's disease	3.61e-05	0.0116	CbGeAlD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	3.59e-05	0.00694	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—IL18—Crohn's disease	3.57e-05	0.00691	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—ICAM1—Crohn's disease	3.56e-05	0.00689	CbGpPWpGaD
Hydrocortisone—ABCB1—mammalian vulva—Crohn's disease	3.56e-05	0.0114	CbGeAlD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	3.51e-05	0.00679	CbGpPWpGaD
Hydrocortisone—Bradycardia—Prednisone—Crohn's disease	3.47e-05	0.000837	CcSEcCtD
Hydrocortisone—Diarrhoea—Azathioprine—Crohn's disease	3.44e-05	0.000829	CcSEcCtD
Hydrocortisone—Haemoglobin—Prednisone—Crohn's disease	3.43e-05	0.000826	CcSEcCtD
Hydrocortisone—Haemorrhage—Prednisone—Crohn's disease	3.41e-05	0.000822	CcSEcCtD
Hydrocortisone—Hallucination—Prednisone—Crohn's disease	3.39e-05	0.000818	CcSEcCtD
Hydrocortisone—Hypersensitivity—Mesalazine—Crohn's disease	3.37e-05	0.000813	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—MLN—Crohn's disease	3.36e-05	0.0065	CbGpPWpGaD
Hydrocortisone—Connective tissue disorder—Prednisone—Crohn's disease	3.35e-05	0.000808	CcSEcCtD
Hydrocortisone—NR3C1—lymph node—Crohn's disease	3.33e-05	0.0107	CbGeAlD
Hydrocortisone—Dizziness—Azathioprine—Crohn's disease	3.32e-05	0.000802	CcSEcCtD
Hydrocortisone—Asthenia—Mesalazine—Crohn's disease	3.29e-05	0.000792	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.25e-05	0.00629	CbGpPWpGaD
Hydrocortisone—Pruritus—Mesalazine—Crohn's disease	3.24e-05	0.000781	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—ACKR2—Crohn's disease	3.22e-05	0.00623	CbGpPWpGaD
Hydrocortisone—Vomiting—Azathioprine—Crohn's disease	3.2e-05	0.000771	CcSEcCtD
Hydrocortisone—Eye disorder—Prednisone—Crohn's disease	3.19e-05	0.000768	CcSEcCtD
Hydrocortisone—Rash—Azathioprine—Crohn's disease	3.17e-05	0.000764	CcSEcCtD
Hydrocortisone—Dermatitis—Azathioprine—Crohn's disease	3.17e-05	0.000764	CcSEcCtD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	3.16e-05	0.00611	CbGpPWpGaD
Hydrocortisone—ABCB1—lymphoid tissue—Crohn's disease	3.16e-05	0.0101	CbGeAlD
Hydrocortisone—Headache—Azathioprine—Crohn's disease	3.15e-05	0.000759	CcSEcCtD
Hydrocortisone—Diarrhoea—Mesalazine—Crohn's disease	3.13e-05	0.000755	CcSEcCtD
Hydrocortisone—ABCB1—digestive system—Crohn's disease	3.12e-05	0.01	CbGeAlD
Hydrocortisone—Immune system disorder—Prednisone—Crohn's disease	3.08e-05	0.000743	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—MLN—Crohn's disease	3.05e-05	0.0059	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Bile acid and bile salt metabolism—ALB—Crohn's disease	3.05e-05	0.00589	CbGpPWpGaD
Hydrocortisone—Arrhythmia—Prednisone—Crohn's disease	3.05e-05	0.000735	CcSEcCtD
Hydrocortisone—Dizziness—Mesalazine—Crohn's disease	3.03e-05	0.00073	CcSEcCtD
Hydrocortisone—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	3.02e-05	0.00585	CbGpPWpGaD
Hydrocortisone—Mental disorder—Prednisone—Crohn's disease	2.99e-05	0.00072	CcSEcCtD
Hydrocortisone—Nausea—Azathioprine—Crohn's disease	2.99e-05	0.00072	CcSEcCtD
Hydrocortisone—Malnutrition—Prednisone—Crohn's disease	2.97e-05	0.000716	CcSEcCtD
Hydrocortisone—Erythema—Prednisone—Crohn's disease	2.97e-05	0.000716	CcSEcCtD
Hydrocortisone—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	2.92e-05	0.00564	CbGpPWpGaD
Hydrocortisone—Vomiting—Mesalazine—Crohn's disease	2.91e-05	0.000702	CcSEcCtD
Hydrocortisone—Rash—Mesalazine—Crohn's disease	2.89e-05	0.000696	CcSEcCtD
Hydrocortisone—Dermatitis—Mesalazine—Crohn's disease	2.88e-05	0.000696	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—TLR4—Crohn's disease	2.87e-05	0.00555	CbGpPWpGaD
Hydrocortisone—Headache—Mesalazine—Crohn's disease	2.87e-05	0.000692	CcSEcCtD
Hydrocortisone—Triamcinolone—PTGS2—Crohn's disease	2.8e-05	0.117	CrCbGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.8e-05	0.00542	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	2.79e-05	0.0054	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	2.79e-05	0.0054	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.76e-05	0.00534	CbGpPWpGaD
Hydrocortisone—Ill-defined disorder—Prednisone—Crohn's disease	2.75e-05	0.000664	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—CCR6—Crohn's disease	2.73e-05	0.00528	CbGpPWpGaD
Hydrocortisone—Nausea—Mesalazine—Crohn's disease	2.72e-05	0.000656	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—IFNG—Crohn's disease	2.71e-05	0.00525	CbGpPWpGaD
Hydrocortisone—Angioedema—Prednisone—Crohn's disease	2.71e-05	0.000654	CcSEcCtD
Hydrocortisone—Malaise—Prednisone—Crohn's disease	2.68e-05	0.000646	CcSEcCtD
Hydrocortisone—Vertigo—Prednisone—Crohn's disease	2.67e-05	0.000643	CcSEcCtD
Hydrocortisone—Syncope—Prednisone—Crohn's disease	2.66e-05	0.000642	CcSEcCtD
Hydrocortisone—Loss of consciousness—Prednisone—Crohn's disease	2.61e-05	0.000629	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—PTGS2—Crohn's disease	2.6e-05	0.00503	CbGpPWpGaD
Hydrocortisone—Convulsion—Prednisone—Crohn's disease	2.57e-05	0.00062	CcSEcCtD
Hydrocortisone—Hypertension—Prednisone—Crohn's disease	2.56e-05	0.000618	CcSEcCtD
Hydrocortisone—Myalgia—Prednisone—Crohn's disease	2.53e-05	0.000609	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—CXCL8—Crohn's disease	2.52e-05	0.00488	CbGpPWpGaD
Hydrocortisone—Anxiety—Prednisone—Crohn's disease	2.52e-05	0.000607	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	2.51e-05	0.000605	CcSEcCtD
Hydrocortisone—Discomfort—Prednisone—Crohn's disease	2.5e-05	0.000602	CcSEcCtD
Hydrocortisone—Oedema—Prednisone—Crohn's disease	2.42e-05	0.000584	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Prednisone—Crohn's disease	2.42e-05	0.000584	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—IL1B—Crohn's disease	2.42e-05	0.00468	CbGpPWpGaD
Hydrocortisone—Infection—Prednisone—Crohn's disease	2.41e-05	0.00058	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—PTGER4—Crohn's disease	2.4e-05	0.00465	CbGpPWpGaD
Hydrocortisone—Shock—Prednisone—Crohn's disease	2.38e-05	0.000575	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.38e-05	0.00461	CbGpPWpGaD
Hydrocortisone—Nervous system disorder—Prednisone—Crohn's disease	2.38e-05	0.000573	CcSEcCtD
Hydrocortisone—Tachycardia—Prednisone—Crohn's disease	2.36e-05	0.00057	CcSEcCtD
Hydrocortisone—Skin disorder—Prednisone—Crohn's disease	2.35e-05	0.000567	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Prednisone—Crohn's disease	2.34e-05	0.000565	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—CCR9—Crohn's disease	2.33e-05	0.00451	CbGpPWpGaD
Hydrocortisone—Anorexia—Prednisone—Crohn's disease	2.31e-05	0.000557	CcSEcCtD
Hydrocortisone—Betamethasone—PTGS2—Crohn's disease	2.29e-05	0.0957	CrCbGaD
Hydrocortisone—Prednisone—ALB—Crohn's disease	2.26e-05	0.0945	CrCbGaD
Hydrocortisone—Norethindrone—ALB—Crohn's disease	2.23e-05	0.0931	CrCbGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	2.22e-05	0.00429	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL10—Crohn's disease	2.21e-05	0.00428	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Prednisone—Crohn's disease	2.21e-05	0.000532	CcSEcCtD
Hydrocortisone—CYP3A7—Metapathway biotransformation—GPX4—Crohn's disease	2.2e-05	0.00425	CbGpPWpGaD
Hydrocortisone—Insomnia—Prednisone—Crohn's disease	2.19e-05	0.000528	CcSEcCtD
Hydrocortisone—NR3C1—Endoderm Differentiation—SMAD3—Crohn's disease	2.18e-05	0.00422	CbGpPWpGaD
Hydrocortisone—Paraesthesia—Prednisone—Crohn's disease	2.18e-05	0.000525	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—GPR65—Crohn's disease	2.17e-05	0.00419	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.15e-05	0.00416	CbGpPWpGaD
Hydrocortisone—Dyspepsia—Prednisone—Crohn's disease	2.13e-05	0.000514	CcSEcCtD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	2.13e-05	0.00411	CbGpPWpGaD
Hydrocortisone—Methyltestosterone—ALB—Crohn's disease	2.12e-05	0.0884	CrCbGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CCR9—Crohn's disease	2.12e-05	0.00409	CbGpPWpGaD
Hydrocortisone—Decreased appetite—Prednisone—Crohn's disease	2.11e-05	0.000508	CcSEcCtD
Hydrocortisone—Fatigue—Prednisone—Crohn's disease	2.09e-05	0.000504	CcSEcCtD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—Crohn's disease	2.07e-05	0.004	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.02e-05	0.0039	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Prednisone—Crohn's disease	2e-05	0.000481	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Prednisone—Crohn's disease	1.98e-05	0.000478	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—Crohn's disease	1.97e-05	0.00381	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	1.97e-05	0.00381	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—GPR65—Crohn's disease	1.97e-05	0.0038	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—CXCL8—Crohn's disease	1.95e-05	0.00376	CbGpPWpGaD
Hydrocortisone—Urticaria—Prednisone—Crohn's disease	1.92e-05	0.000464	CcSEcCtD
Hydrocortisone—Body temperature increased—Prednisone—Crohn's disease	1.91e-05	0.000462	CcSEcCtD
Hydrocortisone—Abdominal pain—Prednisone—Crohn's disease	1.91e-05	0.000462	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—ACKR2—Crohn's disease	1.9e-05	0.00368	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—Crohn's disease	1.9e-05	0.00367	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.86e-05	0.00359	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MLN—Crohn's disease	1.8e-05	0.00349	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	1.79e-05	0.00347	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Prednisone—Crohn's disease	1.78e-05	0.00043	CcSEcCtD
Hydrocortisone—ABCB1—lymph node—Crohn's disease	1.78e-05	0.00572	CbGeAlD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.77e-05	0.00342	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.76e-05	0.0034	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TNF—Crohn's disease	1.76e-05	0.00339	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	1.74e-05	0.00337	CbGpPWpGaD
Hydrocortisone—Asthenia—Prednisone—Crohn's disease	1.74e-05	0.000419	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.74e-05	0.00336	CbGpPWpGaD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	1.72e-05	0.00333	CbGpPWpGaD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	1.72e-05	0.00332	CbGpPWpGaD
Hydrocortisone—Pruritus—Prednisone—Crohn's disease	1.71e-05	0.000413	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	1.71e-05	0.00331	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	1.67e-05	0.00324	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Prednisone—Crohn's disease	1.66e-05	0.0004	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—TAGAP—Crohn's disease	1.65e-05	0.00319	CbGpPWpGaD
Hydrocortisone—Dizziness—Prednisone—Crohn's disease	1.6e-05	0.000386	CcSEcCtD
Hydrocortisone—ABCB1—Allograft Rejection—IL17A—Crohn's disease	1.59e-05	0.00307	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	1.59e-05	0.00307	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CCR6—Crohn's disease	1.54e-05	0.00298	CbGpPWpGaD
Hydrocortisone—Vomiting—Prednisone—Crohn's disease	1.54e-05	0.000371	CcSEcCtD
Hydrocortisone—Rash—Prednisone—Crohn's disease	1.53e-05	0.000368	CcSEcCtD
Hydrocortisone—Dermatitis—Prednisone—Crohn's disease	1.53e-05	0.000368	CcSEcCtD
Hydrocortisone—Headache—Prednisone—Crohn's disease	1.52e-05	0.000366	CcSEcCtD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—Crohn's disease	1.51e-05	0.00291	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—SOCS1—Crohn's disease	1.5e-05	0.00291	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.49e-05	0.00289	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL12B—Crohn's disease	1.48e-05	0.00286	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CXCL8—Crohn's disease	1.45e-05	0.00281	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PLA2G4F—Crohn's disease	1.45e-05	0.0028	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RSPO3—Crohn's disease	1.44e-05	0.00279	CbGpPWpGaD
Hydrocortisone—Nausea—Prednisone—Crohn's disease	1.44e-05	0.000347	CcSEcCtD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.42e-05	0.00275	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.42e-05	0.00275	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—IL6—Crohn's disease	1.42e-05	0.00274	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CCR6—Crohn's disease	1.4e-05	0.00271	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	1.37e-05	0.00266	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SEL1L—Crohn's disease	1.37e-05	0.00264	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—PTGER4—Crohn's disease	1.36e-05	0.00263	CbGpPWpGaD
Hydrocortisone—Dexamethasone—PTGS2—Crohn's disease	1.33e-05	0.0557	CrCbGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IFNG—Crohn's disease	1.3e-05	0.00252	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—SMAD3—Crohn's disease	1.3e-05	0.00251	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCR9—Crohn's disease	1.25e-05	0.00242	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PLA2G4F—Crohn's disease	1.25e-05	0.00241	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PTGER4—Crohn's disease	1.23e-05	0.00239	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—MTMR3—Crohn's disease	1.23e-05	0.00238	CbGpPWpGaD
Hydrocortisone—Testosterone—ALB—Crohn's disease	1.23e-05	0.0513	CrCbGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—Crohn's disease	1.21e-05	0.00234	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	1.2e-05	0.00232	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.19e-05	0.00231	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—Crohn's disease	1.17e-05	0.00225	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.16e-05	0.00225	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—GPR65—Crohn's disease	1.16e-05	0.00225	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—IL3—Crohn's disease	1.16e-05	0.00224	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.16e-05	0.00223	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—Crohn's disease	1.15e-05	0.00222	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.12e-05	0.00217	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.12e-05	0.00217	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—RASGRP1—Crohn's disease	1.12e-05	0.00216	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.09e-05	0.00211	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL10—Crohn's disease	1.08e-05	0.00209	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Crohn's disease	1.07e-05	0.00206	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—MTMR3—Crohn's disease	1.06e-05	0.00205	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PTRF—Crohn's disease	1.06e-05	0.00205	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL3—Crohn's disease	1.05e-05	0.00203	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—RASGRP1—Crohn's disease	1.02e-05	0.00197	CbGpPWpGaD
Hydrocortisone—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.01e-05	0.00195	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	1e-05	0.00193	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	9.62e-06	0.00186	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—FADS1—Crohn's disease	9.59e-06	0.00185	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—GPX4—Crohn's disease	8.98e-06	0.00174	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.84e-06	0.00171	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CXCL8—Crohn's disease	8.8e-06	0.0017	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.77e-06	0.0017	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—GCKR—Crohn's disease	8.67e-06	0.00168	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.63e-06	0.00167	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCR6—Crohn's disease	8.28e-06	0.0016	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—FADS1—Crohn's disease	8.26e-06	0.0016	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—IL2RA—Crohn's disease	8.11e-06	0.00157	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.92e-06	0.00153	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PLA2G4F—Crohn's disease	7.82e-06	0.00151	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GPX4—Crohn's disease	7.74e-06	0.0015	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RBX1—Crohn's disease	7.49e-06	0.00145	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GCKR—Crohn's disease	7.47e-06	0.00145	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	7.38e-06	0.00143	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL2RA—Crohn's disease	7.36e-06	0.00142	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.34e-06	0.00142	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTGER4—Crohn's disease	7.29e-06	0.00141	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7e-06	0.00135	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL6—Crohn's disease	6.8e-06	0.00131	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	6.78e-06	0.00131	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—MTMR3—Crohn's disease	6.65e-06	0.00129	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—UBE2D1—Crohn's disease	6.63e-06	0.00128	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—UBE2D1—Crohn's disease	6.57e-06	0.00127	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	6.38e-06	0.00123	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RIPK2—Crohn's disease	6.37e-06	0.00123	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IFNG—Crohn's disease	6.35e-06	0.00123	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—ZFP36L1—Crohn's disease	6.34e-06	0.00123	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.27e-06	0.00121	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL3—Crohn's disease	6.21e-06	0.0012	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.2e-06	0.0012	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PLA2G4F—Crohn's disease	6.19e-06	0.0012	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	6.14e-06	0.00119	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	6.12e-06	0.00118	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.08e-06	0.00118	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.08e-06	0.00118	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RASGRP1—Crohn's disease	6e-06	0.00116	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	5.99e-06	0.00116	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—STAT3—Crohn's disease	5.93e-06	0.00115	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	5.9e-06	0.00114	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.72e-06	0.00111	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL1B—Crohn's disease	5.66e-06	0.0011	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—JAK2—Crohn's disease	5.45e-06	0.00105	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SOCS1—Crohn's disease	5.44e-06	0.00105	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.42e-06	0.00105	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—DNMT3A—Crohn's disease	5.39e-06	0.00104	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.35e-06	0.00104	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.34e-06	0.00103	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—MTMR3—Crohn's disease	5.27e-06	0.00102	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—MTMR3—Crohn's disease	5.22e-06	0.00101	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—TYK2—Crohn's disease	5.19e-06	0.001	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—FADS1—Crohn's disease	5.18e-06	0.001	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—TNF—Crohn's disease	5.13e-06	0.000993	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CXCL8—Crohn's disease	4.97e-06	0.000962	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—JAK2—Crohn's disease	4.95e-06	0.000957	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GPX4—Crohn's disease	4.85e-06	0.000938	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—SMAD3—Crohn's disease	4.74e-06	0.000917	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SMAD3—Crohn's disease	4.7e-06	0.000908	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GCKR—Crohn's disease	4.69e-06	0.000906	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.67e-06	0.000904	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CXCL8—Crohn's disease	4.52e-06	0.000873	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—Crohn's disease	4.44e-06	0.000858	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	4.44e-06	0.000858	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL2RA—Crohn's disease	4.35e-06	0.000841	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.28e-06	0.000828	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—IL6—Crohn's disease	4.14e-06	0.000801	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—TNF—Crohn's disease	4.11e-06	0.000795	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—FADS1—Crohn's disease	4.1e-06	0.000793	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—FADS1—Crohn's disease	4.07e-06	0.000786	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	3.84e-06	0.000743	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GPX4—Crohn's disease	3.84e-06	0.000743	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GPX4—Crohn's disease	3.81e-06	0.000736	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.79e-06	0.000732	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—MTMR3—Crohn's disease	3.77e-06	0.00073	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GCKR—Crohn's disease	3.71e-06	0.000718	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GCKR—Crohn's disease	3.68e-06	0.000711	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—HSPA1B—Crohn's disease	3.64e-06	0.000704	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.58e-06	0.000693	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.35e-06	0.000648	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PLA2G4F—Crohn's disease	3.35e-06	0.000648	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—MTMR3—Crohn's disease	3.27e-06	0.000632	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—UBE2D1—Crohn's disease	3.19e-06	0.000617	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.18e-06	0.000616	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TYK2—Crohn's disease	3.06e-06	0.000593	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3e-06	0.000581	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—FADS1—Crohn's disease	2.94e-06	0.000568	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.93e-06	0.000567	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—JAK2—Crohn's disease	2.92e-06	0.000565	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—MTMR3—Crohn's disease	2.85e-06	0.000551	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ALB—Crohn's disease	2.76e-06	0.000534	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GPX4—Crohn's disease	2.75e-06	0.000532	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CXCL8—Crohn's disease	2.67e-06	0.000516	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GCKR—Crohn's disease	2.66e-06	0.000514	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—FADS1—Crohn's disease	2.55e-06	0.000492	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL6—Crohn's disease	2.54e-06	0.000491	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.52e-06	0.000488	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTGS2—Crohn's disease	2.41e-06	0.000467	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GPX4—Crohn's disease	2.38e-06	0.000461	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ALB—Crohn's disease	2.38e-06	0.00046	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GCKR—Crohn's disease	2.3e-06	0.000445	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—SMAD3—Crohn's disease	2.28e-06	0.000441	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—FADS1—Crohn's disease	2.22e-06	0.000429	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—STAT3—Crohn's disease	2.15e-06	0.000415	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTGS2—Crohn's disease	2.08e-06	0.000402	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GPX4—Crohn's disease	2.08e-06	0.000402	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.06e-06	0.000399	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.03e-06	0.000392	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GCKR—Crohn's disease	2.01e-06	0.000388	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.75e-06	0.000339	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.65e-06	0.000318	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL6—Crohn's disease	1.5e-06	0.00029	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ALB—Crohn's disease	1.49e-06	0.000288	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.44e-06	0.000278	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—FADS1—Crohn's disease	1.37e-06	0.000264	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.36e-06	0.000264	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS2—Crohn's disease	1.3e-06	0.000252	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GPX4—Crohn's disease	1.28e-06	0.000247	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GCKR—Crohn's disease	1.24e-06	0.000239	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ALB—Crohn's disease	1.18e-06	0.000228	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ALB—Crohn's disease	1.17e-06	0.000226	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS2—Crohn's disease	1.03e-06	0.0002	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS2—Crohn's disease	1.02e-06	0.000198	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ALB—Crohn's disease	8.46e-07	0.000164	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS2—Crohn's disease	7.4e-07	0.000143	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ALB—Crohn's disease	7.33e-07	0.000142	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS2—Crohn's disease	6.41e-07	0.000124	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ALB—Crohn's disease	6.38e-07	0.000123	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS2—Crohn's disease	5.59e-07	0.000108	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ALB—Crohn's disease	3.93e-07	7.61e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.44e-07	6.65e-05	CbGpPWpGaD
